|
Sandostatin LarDrug - Sandostatin Lar The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Octreotide Acetate
Strength -
EQ 10MG BASE/VIAL
Applicant -
NOVARTIS
New Drug Application (NDA) Number -
021008
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Nov 25, 1998
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Novartis Pharmaceuticals Corp
Sandostatin Lar
Sandostatin Eq 1mg Base/ml Injectable; Injection
Sandostatin Lar Eq 10mg Base/vial Injectable; Injection Octreotide Acetate Eq 0.5mg Base/ml Injectable; Injection Octreotide Acetate (preservative Free) Eq 0.05mg Base/ml Injectable; Injection Octreotide Acetate (preservative Free) Eq 0.1mg Base/ml Injectable; Injection Octreotide Acetate (preservative Free) Eq 0.5mg Base/ml Injectable; Injection Sandostatin Eq 0.05mg Base/ml Injectable; Injection Sandostatin Eq 0.1mg Base/ml Injectable; Injection Sandostatin Eq 0.2mg Base/ml Injectable; Injection Sandostatin Eq 0.5mg Base/ml Injectable; Injection NewDrugInformation |